Publication | Closed Access

Sanhuang Jiangtang tablet protects type 2 diabetes osteoporosis via AKT-GSK3β-NFATc1 signaling pathway by integrating bioinformatics analysis and experimental validation

Insulin SignalingSignal TransductionBone Morphogenic ProteinMedicineDiabetesSanhuang Jiangtang TabletType 2Bioinformatics AnalysisOsteoporosisDiabetes MellitusMetabolic SignalingPharmacologyCell BiologyCell SignalingMolecular Signaling